Teva Pharmaceuticals International GmbH v. Eli Lilly and Co.

 
APPEAL NO.
24-1094
OP. BELOW
DCT
SUBJECT
Patent
AUTHOR
Prost

Question(s) Presented

1. “Whether adding functional method-of-use limitations to otherwise nonenabled genus claims renders the claims enabled, as the panel held.”

2. “Whether a specification’s disclosure of species outside the scope of a claimed genus constitutes a disclosure of representative species that can provide written-description support for an otherwise unsupported genus claim.”

Posts About this Case